Co-Diagnostics Profit Margin

Co-Diagnostics's profit margin stands at -6523.04% as of June 2026. That compares with -3586.0% in the prior-year period — down 81.9% year over year. That is below the Healthcare sector average of 14.41%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Co-Diagnostics reported -6523.04% in profit margin versus -3586.0% a year earlier — a 81.9% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Co-Diagnostics sits lower the Healthcare benchmark (14.41%) with a profit margin of -6523.04%. That is roughly 45352.4% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -6523.04% for Co-Diagnostics means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Co-Diagnostics's profit margin evolved across reporting periods, while the comparison chart places CODX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.